Video Experimental Relacionado

Updated: Mar 18, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

El toremifeno interactúa y desestabiliza la glicoproteína del virus del Ébola

Yuguang Zhao¹, Jingshan Ren¹, Karl Harlos¹

¹Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK.

|July 1, 2016

Resumen

Los investigadores determinaron la estructura de la glicoproteína (GP) del virus del Ébola unida a las drogas. Esto revela cómo el toremifeno y el ibuprofeno inhiben la entrada del virus, ofreciendo una nueva estrategia para desarrollar terapias para la enfermedad del virus del Ébola.

Área de la Ciencia:

Biología estructural
Virología
Descubrimiento de drogas

Sus antecedentes:

Los virus del Ébola (EBOV) causan brotes mortales sin tratamientos aprobados.
La glicoproteína EBOV (GP) media la entrada del virus y es un objetivo clave del medicamento.

Objetivo del estudio:

Para determinar la estructura no ligada del EBOV GP.
Para aclarar las estructuras de alta resolución de EBOV GP complejo con toremifeno e ibuprofeno.
Para entender el mecanismo de inhibición de estos medicamentos.

Principales métodos:

Cristalografía de rayos X
Pruebas de desplazamiento térmico

Principales resultados:

Determinó la primera estructura no ligada de EBOV GP.
Se identificó una cavidad de unión para el toremifeno y el ibuprofeno entre las subunidades GP1 y GP2.
La unión del toremifeno desestabilizó significativamente la GP, mientras que el ibuprofeno mostró un efecto marginal.

Conclusiones:

La unión del fármaco al EBOV GP inhibe la entrada del virus al desestabilizar la glicoproteína.
Estos hallazgos proporcionan una base estructural para el desarrollo de nuevas terapias anti-EBOV dirigidas a GP.

Más Videos Relacionados

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Videos de Conceptos Relacionados

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Drugs that Destabilize Microtubules

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...

Antiepileptic Drugs: Potassium Channel Activators

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...